What do women with breast cancer expect from their treatment? Correlates of negative treatment expectations about endocrine therapy

被引:28
作者
Heisig, Sarah R. [1 ]
Shedden-Mora, Meike C. [1 ,2 ]
von Blanckenburg, Pia [3 ]
Rief, Winfried [3 ]
Witzel, Isabell [4 ]
Albert, Ute-Susann [5 ,6 ]
Nestoriuc, Yvonne [1 ]
机构
[1] Univ Hamburg, Clin Psychol & Psychotherapy, Von Melle Pk 5, D-20146 Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Dept Psychosomat Med & Psychotherapy, Hamburg, Germany
[3] Philipps Univ, Dept Clin Psychol & Psychotherapy, Marburg, Germany
[4] Univ Med Ctr Hamburg Eppendorf, Dept Gynecol, Hamburg, Germany
[5] Philipps Univ, Dept Gynecol, Marburg, Germany
[6] Krankenhaus NW Frankfurt, Dept Gynecol & Obstet, Frankfurt, Germany
关键词
QUALITY-OF-LIFE; TAMOXIFEN; BELIEFS; QUESTIONNAIRE; MEDICINES; KNOWLEDGE; SCALE;
D O I
10.1002/pon.4089
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Patients' negative treatment expectations can lead to nocebo-related side effects and non-initiation of treatment. This study aims to identify correlates of treatment expectations in patients with breast cancer before the start of endocrine therapy. Methods: Expectations were assessed in a cross-sectional sample of 166 patients with breast cancer after receiving treatment information. Side effect expectations (one item) and treatment necessity-concern balance (Beliefs about Medicines Questionnaire) were assessed. Correlates were analyzed using regression analyses. The structure of treatment expectations was investigated using a network analysis. Results: About 25% of patients expressed negative expectations. Higher side effect expectations were associated with lower treatment efficacy expectations (beta = 0.20, p = 0.01), higher medication overuse beliefs (beta = 0.17, p = 0.01), and a negative treatment appraisal before study treatment information (beta = 0.17, p = 0.02). A negative necessity-concern balance was associated with lower treatment efficacy expectations (beta = 0.36, p<0.001), lower adherence intention (beta = 0.21, p<0.001), and no knowledge of tumor's receptor status (beta = 0.21, p<0.001); furthermore, it was associated with higher medication harmfulness beliefs (beta = 0.16, p = 0.02), negative treatment pre-appraisal (beta = 0.15, p = 0.01), higher somatosensory amplification (beta = 0.14, p = 0.02), and higher education (beta = 0.12, p = 0.02). The most important network node was the concern that endocrine therapy disrupts life. Conclusion: Negative treatment expectations before treatment start are mainly associated with psychological variables. These results are relevant for patient education in clinical settings. To improve expectations, clinicians might emphasize treatment efficacy and discuss general and specific medication concerns. Improving treatment knowledge could also be beneficial. Copyright (C) 2016 John Wiley & Sons, Ltd.
引用
收藏
页码:1485 / 1492
页数:8
相关论文
共 34 条
[1]  
[Anonymous], VERHALTENSTHERAPI S1
[2]  
[Anonymous], 1999, NORM Users Guide (Version 2)
[3]  
[Anonymous], 2011, HADS D HOSP ANXIETY
[4]   Nonspecific medication side effects and the nocebo phenomenon [J].
Barsky, AJ ;
Saintfort, R ;
Rogers, MP ;
Borus, JF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (05) :622-627
[5]   THE SOMATOSENSORY AMPLIFICATION SCALE AND ITS RELATIONSHIP TO HYPOCHONDRIASIS [J].
BARSKY, AJ ;
WYSHAK, G ;
KLERMAN, GL .
JOURNAL OF PSYCHIATRIC RESEARCH, 1990, 24 (04) :323-334
[6]   Lack of Knowledge of Hormone Receptor Status and Use of Endocrine Therapy in Invasive Breast Cancer [J].
Bell, Robin J. ;
Lijovic, Marijana ;
Fradkin, Pam ;
Bradbury, Jo ;
La China, Maria ;
Schwarz, Max ;
Wolfe, Rory ;
Farrugia, Helen ;
Davis, Susan R. .
JOURNAL OF WOMENS HEALTH, 2009, 18 (12) :1975-1980
[7]   Quality of life and adjuvant tamoxifen treatment in breast cancer patients [J].
Boehm, D. U. ;
Lebrecht, A. ;
Eckhardt, T. ;
Albrich, S. ;
Schmidt, M. ;
Siggelkow, W. ;
Kandelhardt, E. ;
Koelbl, H. .
EUROPEAN JOURNAL OF CANCER CARE, 2009, 18 (05) :500-506
[8]   The Brief Illness Perception Questionnaire [J].
Broadbent, Elizabeth ;
Petrie, Keith J. ;
Main, Jodie ;
Weinman, John .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 2006, 60 (06) :631-637
[9]  
Burstein HJ, 2010, J CLIN ONCOL, V28, P3784, DOI [10.1200/JCO.2009.26.3756, 10.1200/JOP.000082]
[10]   Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial [J].
Buzdar, A. ;
Howell, A. ;
Cuzick, J. ;
Wale, C. ;
Distler, W. ;
Hoctin-Boes, G. ;
Houghton, J. ;
Locker, G. Y. ;
Nabholtz, J. M. .
LANCET ONCOLOGY, 2006, 7 (08) :633-643